Teresa Finley, Chief Marketing And Business Services Officer, Announces Retirement
Apr 25, 2017 13:03 pm UTC| Business
ATLANTA, April 25, 2017 -- UPS (NYSE:UPS) today announced Teresa Finley, Chief Marketing and Business Services Officer, is retiring after 34 years of UPS service. Her distinguished career, primarily in senior...
Teresa Finley, Chief Marketing And Business Services Officer, Announces Retirement
Apr 25, 2017 13:03 pm UTC| Business
ATLANTA, April 25, 2017 -- UPS (NYSE:UPS) today announced Teresa Finley, Chief Marketing and Business Services Officer, is retiring after 34 years of UPS service. Her distinguished career, primarily in senior...
ContraVir Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants
Apr 25, 2017 13:03 pm UTC| Business
EDISON, N.J., April 25, 2017 -- ContraVir Pharmaceuticals, Inc. (“ContraVir”) (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced...
Teresa Finley, Chief Marketing And Business Services Officer, Announces Retirement
Apr 25, 2017 13:03 pm UTC| Business
ATLANTA, April 25, 2017 -- UPS (NYSE:UPS) today announced Teresa Finley, Chief Marketing and Business Services Officer, is retiring after 34 years of UPS service. Her distinguished career, primarily in senior...
Teresa Finley, Chief Marketing And Business Services Officer, Announces Retirement
Apr 25, 2017 13:03 pm UTC| Business
ATLANTA, April 25, 2017 -- UPS (NYSE:UPS) today announced Teresa Finley, Chief Marketing and Business Services Officer, is retiring after 34 years of UPS service. Her distinguished career, primarily in senior...
ContraVir Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants
Apr 25, 2017 13:02 pm UTC| Business
EDISON, N.J., April 25, 2017 -- ContraVir Pharmaceuticals, Inc. (“ContraVir”) (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced...
ContraVir Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants
Apr 25, 2017 13:02 pm UTC| Business
EDISON, N.J., April 25, 2017 -- ContraVir Pharmaceuticals, Inc. (“ContraVir”) (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced...
India–EU FTA Nears Finish Line Ahead of New Delhi Summit